Legal Commentator
Leading Litigator
Lead Negotiator
Author

“Negotiated over $2.86 Billion in opioid harm reduction for the State of Texas ”

Jeffrey B. Simon Wins 'Best Attorney' Award 4 Years In A Row.

Jeffrey B. Simon is a commentator and founding partner of SIMON GREENSTONE PANATIER, PC. Ranked as one of the Top 10 Personal Injury Attorney's within America and Co-chair of the National Opioid Litigation Conference, Mr. Simon brings together medical, legal, and law experts to reduce the social and economic harms of the opioid pandemic.

Attorney Jeffrey B. Simon Secures $1.8 Billion Opioid Settlement for All Texans

Jeffrey B. Simon announced that he and a committee of trial lawyers, along with the Office of the Texas Attorney General, have reached a historic $1.8 billion settlement for Texas.

Texas reaches $290 million settlement with Johnson & Johnson

A $290 million settlement agreement Tuesday with pharmaceutical giant Johnson & Johnson over what the state claims were deceptive marketing tactics that contributed to the ongoing opioid crisis.

We're Suing Fossil Fuel Companies for $1.15 Billion

This industrially caused environmental disease will cause enormous harm, both in terms of human suffering...

social

On this episode of Outside Counsel, Jeffrey B. Simon speaks with trial lawyer Robert "Skeeter" Salim about what recovery from stage four throat cancer actually looked like.

Skeeter describes finishing his final radiation treatment on December 24th — and being told by his care

Trump’s 2nd term will be remembered as a colossal failure, where he succeeded only in enriching himself, his family, and cronies while making Making Americans Poor Again. @Reuters #Corruption #failure #https://apple.news/A1BpSAfssSIea3W74BbOjMg

Great couple. Sorry to see the split. While neither owes the public an explanation for splitting, the one provided seems
incomplete, at best. @SvitolinaNL tried next day to clarify, but didn’t. They need a competent #publicist. Good luck to all in future.

Load More

JEFFREY HAS BEEN FEATURED IN

In the news